Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Alegro Health Corp Reports Changes in Its Board of Directors

Posted on: Wednesday, 6 September 2006, 18:00 CDT

Alegro Health Corp. (TSX VENTURE: AGO), a Canadian health services provider, today reported that at its Annual General Meeting held on June 30, 2006 Mr. Bob Leshchyshen and Dr. Ron Porter were elected to the Company's Board. The Company also reported the resignation of Dr. Bill Orovan from its Board of Directors, effective immediately.

Mr. Leshchyshen is Vice President Operations of Independent Equity Research Corp. and has extensive equities markets experience. He holds Chartered Financial Analyst designation and serves on the audit committees of two other Canadian public companies. Mr. Leshchyshen will Chair the Company's audit committee.

Dr. Porter has practiced medicine in Ontario for 30 years and has lead medical centers serving over 3500 patients. Dr. Porter also has broad experience in executive health, wellness and the pharmaceutical industry.

Brenda Rasmussen, President and CEO of Alegro commented, "We are most pleased that Mr. Bob Leshchyshen and Dr. Ron Porter have joined our Board. They each bring a wealth of experience and knowledge to the Board and we look forward to their counsel in the future. We also are grateful to Dr. Orovan for his service over the past few years and wish him well in the future."

Certain information included in this press release is forward-looking. This information represents our judgment as of this date and is subject to important risks and uncertainties. Such forward-looking information is not a guarantee of performance. The results or events predicted in these statements may differ materially from actual results or events. Consequently, investors should not place any undue reliance on such forward-looking information.

For additional information, investors should consult Alegro's ongoing filings found on SEDAR at www.sedar.com. Unless otherwise required by applicable securities laws, Alegro disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

The TSX Venture Exchange has neither approved nor disapproved of the contents of this press release.

 Contacts: Alegro Health Corp. Brenda Rasmussen President & CEO (416) 496-6166 (416) 499-3520 (FAX) brasmussen@alegrohealth.com

SOURCE: Alegro Health Corp.


Source: MARKET WIRE

More News in this Category


Related Articles



Rating: 2.7 / 5 (10 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required